Breaking news

Why the UAE Is Becoming A Premier Destination For Medical Tourism

by THEFUTURE.TEAM

February 11, 2025

With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

The Future Forbes Realty Global Properties

Cyprus Livestock Industry Navigates Hemorrhagic Fever Impact

by THEFUTURE.TEAM

March 20, 2026

The recent outbreak of hemorrhagic fever has stirred concern among professionals in the livestock sector. Industry insiders report a modest 10% increase in lamb prices, while both production and export volumes of halloumi remain resilient.

Market Dynamics And Price Adjustments

Kostas Leivadotius, President of the Pan-Cypriot Meat Retailers Association, said supply has tightened following movement restrictions. Lamb prices increased from about €11 to €12 after detection of the virus, while pork and beef prices remain unchanged.

Production And Slaughter Statistics

Leivadotius said around 700,000 animals are slaughtered annually in Cyprus, including approximately 20,000 cattle, 450,000 pigs, and 200,000 lambs, with additional supply covered through imports. During last year’s Easter period, more than 50,000 lambs were processed.

Logistical Challenges And Regulatory Responses

Movement restrictions are affecting transport and processing of livestock. Leivadotius said slaughterhouse operations have been disrupted, prompting discussions with authorities on measures to improve transport and processing efficiency.

Regional Implications And Import Adjustments

Following reported cases on Lesvos, Cyprus suspended imports of meat from the area. Imports from Lesvos are typically limited, but alternative supply sources are now being considered.

Maintaining Production Amid Health Concerns

Emphasizing the need for decisive action, Leivadotius urged industry stakeholders and the wider public to heed expert guidance on disease containment. He underlined that accelerated vaccination efforts and stringent movement controls are essential to curb the spread of the virus, thereby allowing production levels to return to normal.

Stability In Halloumi Exports

Michalis Koullouros, representative of the Cyprus Cheese Producers Association, said halloumi exports and prices remain stable, with producers continuing to meet domestic and international demand. Around 80% of Cyprus’ milk production is used for halloumi, with exports accounting for €350 million of a €400 million market. He added that significant livestock losses could affect production levels if the situation worsens.

Future Considerations And Industry Priorities

Looking ahead, industry experts remain watchful of the potential reevaluation of the Protected Designation of Origin (PDO) timeline for halloumi. Although discussions on revising the current schedule have not yet taken center stage, the primary focus now is on containing the outbreak and reinforcing support for livestock producers. This strategy is essential for restoring production and ensuring the industry’s long-term viability.

In summary, while the outbreak of hemorrhagic fever has led to some immediate market adjustments, decisive regulatory action and industry resilience may well steer Cyprus’ livestock and dairy sectors back on track in the near future.